Download Files:
Products Details
Product Description
– CDK7-IN-12 is a potent inhibitor of CDK7. CDK7-IN-12 plays a key role in transcriptional regulation and cell cycle regulation. CDK7-IN-12 effectively inhibit malignant tumor proliferation in vitro and in vivo. CDK7-IN-12 has the potential for the research of cancer disease (extracted from patent WO2021249417A1, compound 43)[1].
Web ID
– HY-144175
Shipping
– Room temperature
Applications
– Cancer-Kinase/protease
Molecular Formula
– C20H19F3N6
References
– [1]Jing Wang, et al. Heterocyclic compounds and their derivatives. Patent WO2021249417A1.
CAS Number
– 2750638-94-7
Molecular Weight
– 400.40
SMILES
– FC(C1=C(C2=CNC3=C2C=CC=C3)N=C(N[C@@H]4CNCCC4)C5=NC=CN51)(F)F
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– 10 mM in DMSO
Target
– CDK
Pathway
– Cell Cycle/DNA Damage
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
